肝硬変治療薬の世界市場2016-2020...市場調査レポートについてご紹介

【英文タイトル】Global Liver Cirrhosis Market 2016-2020

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Disease overview
• Understanding the disease
• Etiology
• Symptoms
• Pathophysiology
• Diagnosis
• Epidemiology
• Prevention
• Treatment
• Impact of alcohol consumption on liver cirrhosis

PART 06: Pipeline portfolio
• Information on pipeline candidates
• Clinical trials for liver cirrhosis

PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 08: Market segmentation by type of molecule
• Biologics
• Small molecules

PART 09: Market segmentation by types of liver cirrhosis

PART 10: Market segmentation by types of liver cirrhosis treatment
• Medications to treat causes of liver cirrhosis
• Medications to treat complications of liver cirrhosis

PART 11: Geographical segmentation
• Liver cirrhosis medication market in Americas
• Market overview
• Market size and forecast
• Liver cirrhosis medication market in EMEA
• Market overview
• Market size and forecast
• Liver cirrhosis medication market in APAC
• Market overview
• Market size and forecast

PART 12: Market drivers
• High prevalence of liver cirrhosis
• Advances in technology
• High unmet medical needs
• Changes in lifestyle

PART 13: Impact of drivers

PART 14: Market challenges
• Use of alternative therapies
• Adverse effects of drugs
• Poor patient adherence
• Stringent regulatory guidelines

PART 15: Impact of drivers and challenges

PART 16: Market trends
• Rise in public awareness
• Increase in R&D
• Use of off-label drugs
• Patient assistance programs

PART 17: Vendor landscape
• Competitive scenario
• F Hoffmann-La Roche
• GlaxoSmithKline
• Gilead Sciences
• Johnson & Johnson
• Merck
• Other prominent vendors

PART 18: Appendix
• List of abbreviations

PART 19: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Stages of liver diseases
Exhibit 03: Causes of liver cirrhosis
Exhibit 04: Diagnosis of liver cirrhosis
Exhibit 05: Effect of alcohol consumption on liver cirrhosis
Exhibit 06: Pipeline molecules for liver cirrhosis
Exhibit 07: Clinical trials by development phase
Exhibit 08: Clinical trials by trial status
Exhibit 09: Global liver cirrhosis medication market 2015-2020 ($ billions)
Exhibit 10: Five forces analysis
Exhibit 11: Four main types of liver cirrhosis
Exhibit 12: Market share by types of liver cirrhosis
Exhibit 13: Types of treatment for liver cirrhosis
Exhibit 14: Global liver cirrhosis medication market segment by geography 2015
Exhibit 15: Global liver cirrhosis medication market segment by geography 2015-2020 ($ millions)
Exhibit 16: Liver cirrhosis medication market in Americas ($ millions)
Exhibit 17: Liver cirrhosis medication market in EMEA ($ millions)
Exhibit 18: Liver cirrhosis medication market in APAC ($ billions)
Exhibit 19: Impact of drivers
Exhibit 20: Impact of drivers and challenges
Exhibit 21: F Hoffmann-La Roche: Business segmentation 2014 by revenue
Exhibit 22: F Hoffmann-La Roche: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 23: F Hoffmann-La Roche: Geographical segmentation by revenue 2014
Exhibit 24: F Hoffmann-La Roche: YoY growth and revenue of Pegasys 2012-2014 ($ billions)
Exhibit 25: F Hoffmann-La Roche: Key takeaways
Exhibit 26: GlaxoSmithKline: Business segmentation by revenue 2014
Exhibit 27: GlaxoSmithKline: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 28: GlaxoSmithKline: Geographical segmentation by revenue 2014
Exhibit 29: GlaxoSmithKline: YoY growth and revenue of Epivir 2012-2014 ($ millions)
Exhibit 30: Gilead Sciences: Geographical segmentation by revenue 2014
Exhibit 31: Gilead Sciences: YoY revenue comparison of Sovaldi 2013-2014 ($ millions)
Exhibit 32: Gilead Sciences: YoY growth and revenue of Viread 2012-2014 ($ millions)
Exhibit 33: Gilead Sciences: Key takeaways
Exhibit 34: Johnson & Johnson: Business segmentation by revenue 2014
Exhibit 35: Johnson & Johnson: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 36: Johnson & Johnson: Geographical segmentation by revenue 2014
Exhibit 37: Johnson & Johnson: YoY growth and revenue of Incivo 2012-2014 ($ millions)
Exhibit 38: Johnson & Johnson: YoY revenue growth of Olysio 2012-2014 ($ millions)
Exhibit 39: Johnson & Johnson: Key takeaways
Exhibit 40: Merck: Business segmentation by revenue 2014
Exhibit 41: Merck: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 42: Merck: Geographical segmentation by revenue 2014
Exhibit 43: Merck: YoY growth and revenue of PegIntron 2012-2014 ($ millions)
Exhibit 44: Merck: YoY growth and revenue of Victrelis 2012-2014 ($ millions)
Exhibit 45: Merck: Key takeaways


【レポート販売概要】

■ タイトル:肝硬変治療薬の世界市場2016-2020
■ 英文:Global Liver Cirrhosis Market 2016-2020
■ 発行日:2016年5月6日
■ 調査会社:Technavio
■ 商品コード:IRTNTR8209
■ 調査対象地域:グローバル
  • 世界の自動支出分析ソリューション市場:Global Automated Spend Analysis Solutions Market 2014-2018
    TechNavio's analysts forecast the Global Automated Spend Analysis Solutions market to grow at a CAGR of 13.64 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing need for expense visibility for intelligent decision making. The Global Automated Spend Analysis Solutions market has also been witnessing the emergence of SaaS-based spend analys …
  • 世界の大気汚染防止システム市場(~2019)
    This report estimates the ’Air Quality Control Systems Market’ in terms of value. The global air quality control systems market is segmented on the basis of their technology type which include flue gas desulfurization (FGD), electrostatic precipitators, fabric Filters, Nitrogen Oxides (NOX) control systems, scrubbers& Mercury control systems. The market is further segmented on the basis of regions …
  • 衝突防止センサーの世界市場2016-2020
    Anti-collision sensors are mainly used to detect obstacles in the way of a vehicle and alert the driver, thus preventing a potential accident. The rising number of road accidents across the globe has led to increased awareness of the need for safety among governments, automobile manufacturers, and consumers. This has increased the demand for anti-collision sensors. Radar is electronic equipment me …
  • Fulvic Acidの世界市場
    Fulvic Acid (CAS 479-66-3) Market Research Report 2013 presents comprehensive data on Fulvic acid markets globally and regionally (Europe, Asia, North America etc.) The Fulvic Acid (CAS 479-66-3) Market Research Report 2013 includes Fulvic acid description, covers its application areas and related patterns. It overviews Fulvic acid market, names Fulvic acid producers and indicates its suppliers. B …
  • Fatty Liver Disease:グローバル臨床試験レビューH1, 2013
    Fatty Liver Disease Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Fatty Liver Disease Global Clinical Trials Review, H1, 2013" provides data on the Fatty Liver Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fatty Liver Disease. It includes an overview of the trial numbers and their recru …
  • 世界の海上防衛・国境警備市場:地域別分析
    Summary This report offers detailed analysis of the global Maritime and Border Security market over the next ten years, and provides extensive market size forecasts by country and sub sector. It covers the key technological and market trends in the Maritime and Border Security market. Key Findings "The Global Maritime and Border Security Market 2015-2025 - Country Analysis: Market Profile" provide …
  • 世界主要国におけるCEA(癌胎児性抗原)検査市場2015
    This report contains 250 pages, 15 tables and presents a detailed analysis of the CEA testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers. The cancer diagnostics market is on …
  • PA Resources AB:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013
    PA Resources AB Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary PA Resources AB Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key ope …
  • ワクチン開発戦略
    Vaccines are one of the most important healthcare advances and have saved millions of lives through immunizing against some of the most deadly diseases. With protection against a number of key viral and bacterial diseases now effectively generated, vaccine R&D is turning to areas of unmet need. Preventative vaccination in adults and against pathogens that affect the developing world is increasingl …
  • マイクロ‐グリッド(小規模発電網)の世界市場予測(~2022年)
    The microgrid market was valued at USD 16.58 Billion in 2015 and is expected to reach USD 38.99 Billion by 2022, at a CAGR of 12.45% during the forecast period. Many countries are focusing on innovations, and expansions are being carried out through rural electrification projects, which would help increase the demand for microgrid systems in the coming years. The microgrid market has been segmente …
  • 2-メルカプトベンゾイミダゾールの世界市場
    2-Mercaptobenzimidazole (CAS 583-39-1) Market Research Report 2014 presents comprehensive data on 2-mercaptobenzimidazole markets globally and regionally (Europe, Asia, North America etc.) The report includes 2-mercaptobenzimidazole description, covers its application areas and related patterns. It overviews 2-mercaptobenzimidazole market, names 2-mercaptobenzimidazole producers and indicates its …
  • 4G技術及びLTEビジネスインテリジェンス(The Definitive Guide to 4G Technology and LTE Business Intelligence)
    Fourth generation (4G) cellular technology represents a huge leap compared to previous generations. The Long Term Evolution (LTE) standard for 4G provides significant capacity gains as well as true end-to-end Internet Protocol (IP) connectivity including voice over IP (VoIP) via voice over LTE (VoLTE). There are significant challenges, such as launching VoLTE, optimizing networks, and integrating …
  • 消費者向けスマート・ウエアラブル技術のグローバル市場(2014-2018)
    About Consumer Smart Wearable Technology Smart wearable technology is defined as the gadgets which are worn on, or attached to, the body, while being used; and use application-enabled advanced computing and wireless technologies to process the inputs. Some of the smart wearable devices are Google Glass, Samsung Gear, and Nike wristbands. These devices are used for fitness, healthcare, lifestyle, a …
  • LTE、M2M及びOTT環境でのMNO向けの次世代ビジネスモデル(Next Generation Business Models for Mobile Network Operators (MNOs) in LTE, M2M, & OTT Environment)
    Mobile network operators (MNOs) are facing unprecedented challenges from M2M evolution, Telematics growth in industry verticals, and consumer preference shift towards data & communication services in 4G LTE network paradigm. MNO’s are also facing and evolving competition driven by Over-the-Top (OTT) players. In our analysis, we use the analogy that the telecom services market is becoming more like …
  • 世界のインターネットサービス市場
    This yearly observatory - report and dataset - provides a comprehensive database covering all principal OTT services for the period of 2010 to 2018 covering service revenues and usages worldwide, regional and on a country level. Case studies of the principal Internet players (Amazon, Apple, Facebook, Google and Microsoft), including their acquisition and platform strategies are looked into, whilst …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。